Evidence map›Paper›PMID 24996559›Full record

ArticleBMC infectious diseases2014

Campylobacter infection in a cohort of rural children in Moramanga, Madagascar.

Rindra Vatosoa Randremanana, Frédérique Randrianirina, Philippe Sabatier, Hanitra Clara Rakotonirina, Arthur Randriamanantena, Iony Manitra Razanajatovo, Rila Ratovoson, Vincent Richard

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Epidemiology of Campylobacter infections among children of 0-24 months of age in South Africa.Archives of public health = Archives belges de sante publique · 2022
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Campylobacter culture fails to correctly detect Campylobacter in 30% of positive patient stool specimens compared to non-cultural methods.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Global Epidemiology of Campylobacter Infection.Clinical microbiology reviews · 2015
    Review
  17. Detection of Campylobacter in human faecal samples in Fiji.Western Pacific surveillance and response journal : WPSAR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Rindra Vatosoa RandremananaUnité Epidémiologie - Institut Pasteur de Madagascar, BP 1274, Antananarivo 101, Madagascar. rrandrem@pasteur.mg.
Frédérique Randrianirina
Philippe Sabatier
Hanitra Clara Rakotonirina
Arthur Randriamanantena
Iony Manitra Razanajatovo
Rila Ratovoson
Vincent Richard
Institut Pasteur de Madagascar · MGInstitut Pasteur · FRCentre National de la Recherche Scientifique · FRInstitut Pasteur de Dakar · SN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCampylobacter infection is the most common cause of bacterial gastroenteritis in developing countries, including Madagascar. Reports of pathogenicity have not been consistent and repeated exposures over time seem to lead to the development of protective immunity in developing areas. We conducted this study to support evidence for these hypotheses by exploring the association between infection and age, the reoccurrence of infection and the pathogenicity of Campylobacter.

methodsWe carried out a community-based longitudinal study of children under the age of 24 months in two rural villages in Moramanga, Madagascar. Children were visited twice a week and a stool specimen was collected in cases of diarrhoea. Stools specimens were collected bimonthly from all children enrolled, regardless of symptoms. Children were followed-up until the age of 36 months.

resultsBetween January 2010 and May 31st 2012, 508 children were included in the cohort. We detected 319 episodes of Campylobacter infection in total, and 43.3% (n = 220) of the children had at least one episode of intestinal Campylobacter infection. The rate of Campylobacter isolation from stool specimens was 9.3%. The annual incidence rate for symptomatic Campylobacter infection was 0.05 episodes/child. The probability of Campylobacter infection was highest between the ages of six and 23 months. Taking children under six months of age as the reference group, the age-specific odds ratio for the association was 5.0 (95% CI: 2.9-8.6) for children aged six to 11 months, 5.7 (95% CI: 3.3-10.0) for children aged 12 to 17 months and 3.3 (95% CI: 1.8-5.8) for children aged 18 to 23 months. A second episode of infection occurred 63 days after the first episode in children with primary infections, and after 137 days in children with multiple infections (p < 0.01). First episodes of Campylobacter infection were associated with diarrhoea (odds ratio = 16.1; 95% CI: 1.8-140.8).

conclusionOur findings suggest that protective immunity to Campylobacter may be acquired over time, following repeated exposures. However, Campylobacter infection prevention measures should be reinforced in the first year of life, as this age seems to be associated with the highest risk of diarrhoea during Campylobacter infection.

Indexed as

CampylobacterCampylobacter InfectionsChildChild, PreschoolChild WelfareCohort StudiesDeveloping CountriesDiarrheaFemaleHumansInfantLongitudinal StudiesMadagascarMaleOdds RatioRural Population

Identifiers

PMID24996559
PMCPMC4094412
OpenAlexW2041466116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.